1 – 69 of 69
- show: 250
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Low-grade inflammation in persons with recently diagnosed type 2 diabetes : The role of abdominal adiposity and putative mediators
2024) In Diabetes, Obesity and Metabolism(
- Contribution to journal › Article
-
Mark
Vulvovaginal candidiasis and type 2 diabetes : A nationwide retrospective cohort study
(
- Contribution to journal › Article
- 2023
-
Mark
Model-based predictions on health benefits and budget impact of implementing empagliflozin in people with type 2 diabetes and established cardiovascular disease
(
- Contribution to journal › Article
-
Mark
Burden of established cardiovascular disease in people with type 2 diabetes and matched controls : Hospital-based care, days absent from work, costs and mortality
(
- Contribution to journal › Article
- 2021
-
Mark
The majority of people with type 1 diabetes and multiple daily insulin injections benefit from using continuous glucose monitoring : An analysis based on the GOLD randomized trial (GOLD-5)
(
- Contribution to journal › Article
-
Mark
Interaction of diabetes genetic risk and successful lifestyle modification in the Diabetes Prevention Programme
(
- Contribution to journal › Article
- 2020
-
Mark
Persistent whole day meal effects of three dipeptidyl peptidase-4 inhibitors on glycaemia and hormonal responses in metformin-treated type 2 diabetes
(
- Contribution to journal › Article
-
Mark
Days absent from work as a result of complications associated with type 2 diabetes : Evidence from 20 years of linked national registry data in Sweden
(
- Contribution to journal › Article
-
Mark
Peptide YY (1–36) peptides from phylogenetically ancient fish targeting mammalian neuropeptide Y1 receptors demonstrate potent effects on pancreatic β-cell function, growth and survival
(
- Contribution to journal › Article
- 2019
-
Mark
Metformin is the key factor in elevated plasma growth differentiation factor-15 levels in type 2 diabetes : A nested, case–control study
(
- Contribution to journal › Article
-
Mark
Association between diabetic eye disease and other complications of diabetes : Implications for care. A systematic review
(
- Contribution to journal › Scientific review
-
Mark
Investigating optimal β-cell-preserving treatment in latent autoimmune diabetes in adults : Results from a 21-month randomized trial
(
- Contribution to journal › Article
- 2018
-
Mark
Different glucagon effects during DPP-4 inhibition versus SGLT-2 inhibition in metformin-treated type 2 diabetes patients
(
- Contribution to journal › Article
-
Mark
Semaglutide induces weight loss in subjects with type 2 diabetes regardless of baseline BMI or gastrointestinal adverse events in the SUSTAIN 1 to 5 trials
(
- Contribution to journal › Article
-
Mark
Effects on the glucagon response to hypoglycaemia during DPP-4 inhibition in elderly subjects with type 2 diabetes : A randomized, placebo-controlled study
(
- Contribution to journal › Article
-
Mark
MicroRNAs in islet hormone secretion
(
- Contribution to journal › Scientific review
-
Mark
Effect of single-dose DPP-4 inhibitor sitagliptin on β-cell function and incretin hormone secretion after meal ingestion in healthy volunteers and drug-naïve, well-controlled type 2 diabetes subjects
(
- Contribution to journal › Article
- 2017
-
Mark
Effects of DPP-4 inhibitor linagliptin and GLP-1 receptor agonist liraglutide on physiological response to hypoglycaemia in Japanese subjects with type 2 diabetes : A randomized, open-label, 2-arm parallel comparative, exploratory trial
(
- Contribution to journal › Article
-
Mark
Sustained influence of metformin therapy on circulating glucagon-like peptide-1 levels in individuals with and without type 2 diabetes
(
- Contribution to journal › Article
-
Mark
Alain Ktorza, PhD
(
- Contribution to journal › Debate/Note/Editorial
- 2016
-
Mark
Mixed meal diminishes glucose excursion compared to glucose by several adaptive mechanisms in man.
(
- Contribution to journal › Article
- 2015
-
Mark
The Islet and Metabolism Keep Time
(
- Contribution to journal › Debate/Note/Editorial
- 2014
-
Mark
Glucagon dynamics during hypoglycaemia and food-re-challenge following treatment with vildagliptin in insulin-treated patients with type 2 diabetes.
(
- Contribution to journal › Article
-
Mark
The mind and the belly: a glance at how the nervous system directs metabolism
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Pronounced Reduction Of Postprandial Glucagon By Lixisenatide: A Meta-Analysis Of Randomized Clinical Trials.
(
- Contribution to journal › Article
- 2013
-
Mark
Dipeptidyl peptidase-4 inhibitors and cardiovascular risk: a meta-analysis of randomized clinical trials
(
- Contribution to journal › Article
-
Mark
Sitagliptin and pioglitazone provide complementary effects on postprandial glucose and pancreatic islet cell function
(
- Contribution to journal › Article
-
Mark
Glucose-lowering effect of the DPP-4 inhibitor sitagliptin after glucose and non-glucose macronutrient ingestion in non-diabetic subjects.
(
- Contribution to journal › Article
-
Mark
Shifting the paradigm of islet inflammation-good guy or bad guy?
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Long-term efficacy and safety comparison of liraglutide, glimepiride and placebo, all in combination with metformin in type 2 diabetes: 2-year results from the LEAD-2 study
(
- Contribution to journal › Article
- 2012
-
Mark
Pancreatic β-cell dysfunction, expression of iNOS and the effect of phosphodiesterase inhibitors in human pancreatic islets of type 2 diabetes.
(
- Contribution to journal › Article
-
Mark
Glycaemic efficacy of glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors as add-on therapy to metformin in subjects with type 2 diabetes-a review and meta analysis.
(
- Contribution to journal › Article
-
Mark
The hyperstimulated beta-cell: prelude to diabetes?
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Using albumin to improve the therapeutic properties of diabetes treatments.
(
- Contribution to journal › Article
- 2011
-
Mark
Editorial: Long in the shade, glucagon re-occupies centre court
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Mechanisms of Action of the DPP-4 Inhibitor Vildagliptin in Man.
(
- Contribution to journal › Scientific review
-
Mark
Gastric bypass surgery, but not caloric restriction, decreases dipeptidyl peptidase 4 activity in obese patients with type 2 diabetes.
(
- Contribution to journal › Article
-
Mark
Can sulphonylurea addition to lifestyle changes help to delay diabetes development in subjects with impaired fasting glucose? The Nepi ANtidiabetes StudY (NANSY)
(
- Contribution to journal › Article
-
Mark
Clinical evidence and mechanistic basis for vildagliptin's action when added to metformin.
(
- Contribution to journal › Article
-
Mark
The future of incretin-based therapy: novel avenues-novel targets.
(
- Contribution to journal › Article
-
Mark
Dissociated incretin hormone response to protein versus fat ingestion in obese subjects.
(
- Contribution to journal › Article
- 2010
-
Mark
A low glycaemic diet improves oral glucose tolerance but has no effect on β-cell function in C57BL/6J mice.
(
- Contribution to journal › Article
-
Mark
What ails the beta-cell?
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Vildagliptin add-on to metformin produces similar efficacy and reduced hypoglycaemic risk compared with glimepiride, with no weight gain: results from a 2-year study
(
- Contribution to journal › Article
- 2009
-
Mark
Fifty-two-week efficacy and safety of vildagliptin vs. glimepiride in patients with type 2 diabetes mellitus inadequately controlled on metformin monotherapy
(
- Contribution to journal › Article
-
Mark
Identification of T1D susceptibility genes within the MHC region by combining protein interaction networks and SNP genotyping data
(
- Contribution to journal › Article
-
Mark
beta-Cell research - A decade of rapid growth
(
- Contribution to journal › Article
-
Mark
Dissociated incretin response to oral glucose at 1 year after restrictive vs. malabsorptive bariatric surgery
(
- Contribution to journal › Article
-
Mark
Effect of adjunct metformin treatment on levels of plasma lipids in patients with type 1 diabetes
(
- Contribution to journal › Article
-
Mark
Functional SOCS1 polymorphisms are associated with variation in obesity in whites
(
- Contribution to journal › Article
-
Mark
Inhibitory effect of kisspeptins on insulin secretion from isolated mouse islets.
(
- Contribution to journal › Article
-
Mark
Genetic basis of beta-cell dysfunction in man.
(
- Contribution to journal › Article
- 2008
-
Mark
Efficacy and tolerability of vildagliptin in drug-naive patients with type 2 diabetes and mild hyperglycaemia
(
- Contribution to journal › Article
-
Mark
Evidence that vildagliptin attenuates deterioration of glycaemic control during 2-year treatment of patients with type 2 diabetes and mild hyperglycaemia
(
- Contribution to journal › Article
-
Mark
Retinopathy in subjects with impaired fasting glucose The NANSY – Eye Study, Baseline report
(
- Contribution to journal › Article
-
Mark
Effects of insulin vs. glibenclamide in recently diagnosed patients with type 2 diabetes: a 4-year follow-up
(
- Contribution to journal › Article
- 2007
-
Mark
Targeting hyperglycaemia with either metformin or repaglinide in non-obese patients with type 2 diabetes: results from a randomized crossover trial
(
- Contribution to journal › Article
-
Mark
Prediction of fat-free body mass from bioelectrical impedance among 9-to 11-year-old Swedish children
(
- Contribution to journal › Article
- 2006
-
Mark
Residual risk for acute stroke in patients with type 2 diabetes and hypertension in primary care: Skaraborg Hypertension and Diabetes Project.
(
- Contribution to journal › Article
- 2005
-
Mark
Inverse association between plasma homocysteine, sulphonylurea exposure and physical activity: a community-based sample of type 2 diabetes patients in the Skaraborg hypertension and diabetes project
(
- Contribution to journal › Article
-
Mark
Islet adaptation to insulin resistance: mechanisms and implications for intervention.
(
- Contribution to journal › Scientific review
- 2004
-
Mark
Atrial fibrillation and its association with type 2 diabetes and hypertension in a Swedish community.
(
- Contribution to journal › Article
- 2003
-
Mark
Metabolic disorders associated with uncontrolled hypertension.
(
- Contribution to journal › Article
-
Mark
Socio-demographic and psychosocial factors are associated with features of the metabolic syndrome. The Women's Health in the Lund Area (WHILA) study.
(
- Contribution to journal › Article
-
Mark
Decreasing levels of tumour necrosis factor alpha and interleukin 6 during lowering of body mass index with orlistat or placebo in obese subjects with cardiovascular risk factors.
(
- Contribution to journal › Article
- 2002
-
Mark
Efficacy, effectiveness and safety of sulphonylurea-metformin combination therapy in patients with type 2 diabetes.
(
- Contribution to journal › Scientific review
- 2001
-
Mark
Effects and serum levels of glibenclamide and its active metabolites in patients with type 2 diabetes
(
- Contribution to journal › Article
-
Mark
Impaired glucose metabolism and obesity in Swedish patients with borderline isolated systolic hypertension: Skaraborg Hypertension and Diabetes Project
(
- Contribution to journal › Article
- 1999
-
Mark
Differences in treatment and metabolic abnormalities between normo- and hypertensive patients with type 2 diabetes: the Skaraborg Hypertension and Diabetes Project
(
- Contribution to journal › Article